Skip to main content

Table 1 Parameters of binomial distributions

From: A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials

 

Response

Non-toxicity

Negative

XR1-~B(N1-,pR-)

XT1-~B(N1-,pT-)

XR2-~B(N2-,pR-)

XT2-~B(N2-,pT-)

Positive

XR1+~B(N1+,pR+)

XT1+~B(N1+,pT+)

XR+~B(N+,pR+)

XT+~B(N+,pT+)

XR2e+~B(N2e+,pR+)

XT2e+~B(N2e+,pT+)